Mendel AI: Clinical Trials

3 trials sponsored by Mendel AI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Mendel AI: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
Chart review - Prostate Cancer
Active not recruitingUniversity of Pennsylvania3002025-04-042026-06-17
Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening
Chart review - Cancer
CompletedUniversity of Pennsylvania3552023-08-182025-07-25
The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy
Venlafaxine, Memantine - Oncology Pain, Chemotherapy-induced Peripheral Neuropathy
Phase 2 / Phase 3UnknownMendel AI602021-02-152021-02-04

Conditions studied

Cancer Pain (1)  ·  Neoplasms (1)  ·  Prostatic Neoplasms (1)

Interventions

Memantine (1)  ·  Venlafaxine Hydrochloride (1)

Countries

United States (2)  ·  Egypt (1)

Results publications

PMID 41634037